Employment |
2020 - Present | Finger Lakes Dermatology, Dryden NY
Founder and CEO |
2017 - 2020 | Cayuga Medical Associates, Ithaca NY |
2013 - 2017 | The Corvallis Clinic, Corvallis OR |
Licensing |
Present | American Board of Dermatology Certified
New York Unrestricted Medical License |
Education |
2010 - 2013 | Resident, Dermatology
Wake Forest Baptist Health, Winston-Salem, NC |
2007 - 2010 | Senior Clinical Research Fellow
Center For Dermatology Research, Wake Forest Baptist Health, Winston Salem, NC |
2006 - 2007 | Transitional Year Residency Program
Mercy Catholic Medical Center, Darby, PA |
2002 - 2006 | Medical Doctorate
Jefferson Medical College, Philadelphia, PA |
1997 - 2001 | Bachelor of Arts in Biology
LaSalle University, Philadelphia, PA |
Honors |
2012 | DermMentors Resident of Distinction Award |
2009 | American Acne and Rosacea Society Research Grant Recipient |
2006-07 | Chief Resident – Transitional Residency Program |
2005 | Dermatology abroad - Brisbane, Australia |
2005 | American Medical Student Association – Jefferson Committee Member |
2005 | Jefferson Students for Dermatology – Member / Organizer |
2004 | Jefferson Free Online Study Aid – Question writer |
1998-2001 | Graduated Magnum Cum Laude Phi Alpha Beta (LaSalle Biology Club) – President
LaSalle Environmental Workshop & Green Campus Day
Dean’s list |
Research experience |
2014 - 2016 | The Corvallis Clinic Corvallis, OR
Dr. Yentzer worked on several Phase III clinical trials for psoriasis treatments, including Humira, Stelara and Cosentyx. |
2007 - 2010 | Wake Forest University Baptist Medical Center Winston Salem, NC
Working for the Center for Dermatology Research, Dr. Yentzer conducted health services and health outcomes research. His work focused on adherence to dermatologic treatments, the relationship between efficacy of therapy and adherence, and interventions to increase adherence to treatment regimens. |
2003 | Thomas Jefferson University Philadelphia, PA
Dr. Yentzer pioneered using zebrafish as a model for studying inhibitors of the Epidermal Growth Factor Receptor (EGFR) under direction of Dr. Ulrich Rodeck. |
2001 - 2002 | Medical Research Institute for Chemical Defense (USAMRID) Aberdeen, MD
Working with Dr. John Schlager, Dr. Yentzer used molecular subtraction libraries to study gene regulation in keratinocytes after exposure to the chemical warfare agents sulfur mustard and VX gas. |
2001 | Wistar Institute Philadelphia, PA
-Working in Dr. Meenhard Herlyn’s lab, Dr. Yentzer examined the potential relationship between the regulation of angiogenesis and invasive characteristics of melanoma. |
1999 & 2000 | Veterans Affairs Medical Center Coatesville, PA
Working with Dr. Greg Golden, Dr. Yentzer helped conduct molecular genetic studies of cocaine-kindled seizures and anticonvulsant drugs. |